Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
FT-6876
i
Other names:
FT-6876
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Novo Nordisk
Drug class:
CBP inhibitor, EP300 inhibitor
Related drugs:
‹
eribulin mesylate (47)
PRI724 (5)
CCS1477 (4)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
eribulin mesylate (47)
PRI724 (5)
CCS1477 (4)
AU-18069 (0)
AUR-107 (0)
E7386 (0)
EP31670 (0)
NEO1132 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AR positive
Breast Cancer
AR positive
Breast Cancer
FT-6876
Sensitive: D – Preclinical
FT-6876
Sensitive
:
D
FT-6876
Sensitive: D – Preclinical
FT-6876
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login